Ad is loading...
VFINX
Price
$551.85
Change
+$1.93 (+0.35%)
Updated
Nov 22 closing price
VSMPX
Price
$270.87
Change
+$1.44 (+0.53%)
Updated
Nov 22 closing price
Ad is loading...

VFINX vs VSMPX

Header iconVFINX vs VSMPX Comparison
Open Charts VFINX vs VSMPXBanner chart's image
Vanguard 500 Index Investor
Price$551.85
Change+$1.93 (+0.35%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Pls
Price$270.87
Change+$1.44 (+0.53%)
VolumeN/A
CapitalizationN/A
VFINX vs VSMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VFINX vs. VSMPX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VFINX is a StrongSell and VSMPX is a StrongSell.

FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.73T vs. VFINX (1.28T). VSMPX pays higher dividends than VFINX: VSMPX (1.36) vs VFINX (1.24). VFINX was incepted earlier than VSMPX: VFINX (48 years) vs VSMPX (10 years). VFINX (2.00) and VSMPX (2.00) have comparable annual turnover. VFINX has a lower initial minimum investment than VSMPX: VFINX (0) vs VSMPX (100000000). VSMPX (31.19) and VFINX (30.57) have marching annual gain over last year. VFINX (91.24) and VSMPX (87.25) have equivalent 5 years return.
VFINXVSMPXVFINX / VSMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence48 years10 years-
Gain YTD25.01124.446102%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28T1.73T74%
Annual Yield % from dividends1.241.3691%
Returns for 1 year30.5731.1998%
Returns for 3 years27.0723.16117%
Returns for 5 years91.2487.25105%
Returns for 10 years189.02N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS8.130.28
+3.57%
iTeos Therapeutics
CNC60.351.25
+2.12%
Centene Corp
SKY100.081.94
+1.98%
Champion Homes Inc
CNNE20.770.23
+1.12%
Cannae Holdings
CLDI2.15-0.14
-6.11%
Calidi Biotherapeutics